Hisse Senetlerindeki Sıralama
#26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Hisse Fiyatı
$0.12164306
Son senkronizasyon: 2024-11-11
Ticaret PharmAust Limited (PAA)
B piyasa değeri ile PAA fiyatı
Piyasa Değeri PharmAust Limited(PAA)
Piyasa Değeri: $38.53M
August 2026 itibarıyla PharmAust Limited şirketinin piyasa değeri $38.53M. Bu, verilerimize göre PharmAust Limited şirketini dünyanın en değerli 26700th. şirketi yapar. Piyasa değeri, halka açık bir şirketin tedavüldeki hisse senetlerinin toplam piyasa değeri olup, bir şirketin değerini ölçmek için yaygın olarak kullanılır.
PharmAust Limited piyasa değeri geçmişi (2001 - 2026)
En Popüler 5 stocks ile karşılaştırıldığında PAA
| PAA’in Fiyatı |
|
B Varlığı |
B’nin Piyasa Değeri |
Sonuçlar |
|
|
|
|
$5.307T
|
+13,774,337.61%
|
|
|
|
|
$4.697T
|
+12,192,126.35%
|
|
|
|
|
$4.147T
|
+10,763,080.60%
|
|
|
|
|
$3.584T
|
+9,301,304.15%
|
|
|
|
|
$2.834T
|
+7,356,737.38%
|
